Patent application number | Description | Published |
20090074374 | Curable Composition for Optical Material and Optical Waveguide - A curable composition for an optical material including a specific silicon-containing polymer (A), a specific epoxy resin (B) and an energy ray-sensitive cationic polymerization initiator (C) as essential components. | 03-19-2009 |
20090169484 | IRON-SALEN COMPLEX - The present invention provides a drug delivery system that overcomes conventional technical problems and that is readily put to practical use. Iron-salen complexes represented by General Formula (I) below. The invention renders iron-salen complexes magnetic, which can thus be used as drugs that can be delivered to affected areas in the body using the inherent magnetic properties of the drug without employing carriers composed of magnetic substances as has been done hitherto. | 07-02-2009 |
20090239420 | CONNECTOR FOR CONNECTING ELECTRONIC COMPONENT - Provided is a connector for connecting an electronic component, which reduces noise radiation when the electronic component is connected to a substrate through the connector and driven. In a connector ( | 09-24-2009 |
20090285759 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - A drug comprises an organic or inorganic compound, and is made magnetic by modification of side chains and/or crosslinking between side chains. | 11-19-2009 |
20090311163 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - It is intended to provide a drug delivery system which makes it possible to solve the existing technical problems and is easily usable in practice. A drug, which comprises an organic compound or an inorganic compound and has been magnetized by modifying a side chain and/or crosslinking side chains, is induced by a magnetic force into target tissues or an affected part. | 12-17-2009 |
20110188556 | RECEIVING DEVICE AND RADIO QUALITY CALCULATION METHOD - A reception device calculates a radio quality in a downlink by using a plurality of pilot symbols transmitted from a base station. The reception device includes a correlation calculation unit and a radio quality calculation unit. The correlation calculation unit calculates a correlation value between a first pilot symbol and a second pilot symbol on a time axis or a correlation value there between on a frequency axis. If the correlation value obtained by the correlation calculation unit exceeds a predetermined threshold value, the radio quality calculation unit calculates a radio quality in the downlink by using a reception quality of the first pilot symbol and a reception quality of the second pilot symbol. | 08-04-2011 |
20120029167 | AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND - A drug using the magnetic properties of a metal salen complex as represented by the following general formula in order to magnetize the intended drug by chemically binding the drug to a metal salen complex so that the drug can be delivered to the target diseased site. The drug can be delivered to the diseased site using the magnetic properties of the drug per se without using a carrier made of a magnetic substance as in the conventional methods. | 02-02-2012 |
20120178393 | RECEIVING APPARATUS AND INTERFERENCE POWER ESTIMATION METHOD - Provided are a receiving apparatus and an interference power estimation method that can perform interference power estimation with high accuracy even when correlation in a fading variation between reference signals is low and obtain accurate receiving quality. The interference power estimation method according to the present invention receives a plurality of discontinuous reference signals on the time/frequency plane, extracts the reference signals from the received signal, linear-combines channel variation values obtained from reference signals surrounding a reference signal of a specific time/frequency on the time/frequency plane with predetermined weighting and estimates interference power using the linear-combined value resulting from the linear combining. | 07-12-2012 |
20120259155 | MAGNETIC BODY AND DRUG DELIVERY CONTROL DEVICE USING MAGNETIC BODY - A magnetic body may be suitably applied to a drug delivery system using magnetism. Furthermore, a drug delivery control device allows the magnetic body to be suitably applied to drug delivery. The magnetic body includes a magnet and a cover part attached to an edge of the magnet. The cover part is composed of a material with high magnetic permeability, and a ratio of a length to a radius of the cover part is 10:1 to 7:3. The drug delivery control device includes the magnetic body, a head for supporting the magnetic body and a drive mechanism of the head that causes the head to operate along a projected region formed by the affected area with respect to a surface of a tissue. A magnetic field is applied from the magnetic body to the affected area where a magnetic drug is administered. | 10-11-2012 |
20120283505 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - It is intended to provide a drug delivery system which makes it possible to solve the existing technical problems and is easily usable in practice. A drug, which comprises an organic compound or an inorganic compound and has been magnetized by modifying a side chain and/or crosslinking side chains, is induced by a magnetic force into target tissues or an affected part. | 11-08-2012 |
20130029399 | METAL SALEN COMPLEX DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF - A metal-salen complex derivative with an excellent yield and stability is provided and a method for producing such a metal-salen complex derivative is provided. The present invention provides: metal-salen complex derivative obtained by allowing a target component composed of at least one of an enzyme, an antibody, an antigen, a peptide, an amino acid, an oligonucleotide, a protein, a nucleic acid, and a medical molecule to bind to a metal-salen complex via an amide bond or a disulfide bond; a method for producing such a metal-salen complex derivative. | 01-31-2013 |
20130090539 | FLUOROCHROME MATERIAL AND METHOD FOR USING THE SAME - It is an object of the present invention to extend the usefulness of an iron-salen complex. The present invention is a new fluorochrome material containing Chemical Formula (I) below. However, M is Fe, Cr, Mn, Co, Ni, Mo, Ru, Rh, Pd, W, Re, Os, Ir, Pt, Nd, Sm, Eu, or Gd. | 04-11-2013 |
20130131367 | ANTI-BRAIN-TUMOR DRUG - A drug containing a metal-salen complex compound which is effective for a brain tumor is provided. The present invention is an anti-brain-tumor drug containing a metal-salen complex compound represented by the following Chemical Formula (I). In the formula, M represents a metal atom which is Fe, Cr, Mn, Co, Ni, Mo, Ru, Rh, Pd, W, Re, Os, Ir, Pt, Nd, Sm, Eu, or Gd, and X represents a halogen atom. | 05-23-2013 |
20140046021 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND - The molecular structures of metal-salen complexes which exerts pharmacological effects are clarified and the metal-salen complexes having such molecular structures and their derivatives are provided. A metal-salen complex compound is characterized in that a metal atom part in each of multiple molecules of the metal-salen complex or its derivative is multimerized via water. | 02-13-2014 |
20140206635 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG - A metal-salen complex compound, which exhibits excellent noninvasiveness and can be efficiently transferred to an affected site, a local anesthetic containing this metal-salen complex compound, and an antineoplastic drug containing this metal-salen complex compound are provided. Regarding the metal-salen complex compound, a metal atom part in each of two molecules of a metal-salen complex or a derivative of the metal-salen complex is dimerized via water, and the metal-salen complex compound is mixed with a base to produce an ointment. | 07-24-2014 |
20140214380 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - It is intended to provide a drug delivery system which makes it possible to solve the existing technical problems and is easily usable in practice. A drug, which comprises an organic compound or an inorganic compound and has been magnetized by modifying a side chain and/or crosslinking side chains, is induced by a magnetic force into target tissues or an affected part. | 07-31-2014 |
20140235684 | METAL-SALEN COMPLEX COMPOUND RESPONSIVE DRUG AND INTRA-CORPOREAL BEHAVIOR CONTROL SYSTEM FOR METAL-SALEN COMPLEX COMPOUND - A metal-salen complex compound responsive drug, which has an antidotal property capable of neutralizing cytotoxicity of a metal-salen complex compound, and an intra-corporeal behavior control system for the metal-salen complex compound are provided. This metal-salen complex compound responsive drug contains an effective amount of a metal chelating agent to suppress side effects by the metal-salen complex compound. | 08-21-2014 |
20140302604 | RADICAL INHIBITOR - A new radical inhibitor, a composition containing the new radical inhibitor, and a radical generation inhibition method using the new radical inhibitor are provided. A radical inhibitor according to the present invention contains a salen complex compound of a bivalent metal. | 10-09-2014 |
20140323566 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND - A new self-magnetic metal-salen complex compound and its derivatives are provided. The present invention is a metal-salen complex compound including any one of the following compounds. | 10-30-2014 |
20150028250 | MAGNETIC COMPOSITION AND ITS PRODUCTION METHOD - A magnetic composition containing a metal-salen complex compound which can be securely guided by a magnetic field to a target area to be preferably treated, and a method for producing the magnetic composition are provided. The magnetic composition is prepared by dispersing magnetic particles, which are obtained by coating a metal-salen complex compound with a dispersant, in a polar solvent by means of the dispersant. Furthermore, the magnetic composition production method includes a first step of mixing the metal-salen complex compound with the dispersant in an organic solvent and coating the metal-salen complex compound with the dispersant and a second step of dispersing the metal-salen complex in a polar solvent. | 01-29-2015 |
20150318095 | MAGNETIC SUBSTANCE AND MAGNETIC SUBSTANCE MANUFACTURING METHOD - [Object] A magnetization technique that enhances magnetic properties of an organic compound is provided without damaging properties of the organic compound or while maintaining the structure of the organic compound. | 11-05-2015 |
20150336998 | MAGNETIC SUBSTANCE - The present disclosure relates to a ferromagnetic substance containing a crystal of a metal complex molecule in which a heterocycle is bonded to metal, the metal of the metal complex molecule is bonded to the metal of another metal complex via oxygen as a electron donor, and the ferromagnetic substance has a ferromagnetic property balanced with stability of crystals based on a metal—electron donor—metal bond angle that is from 130° to 160°. The present disclosure also relates to a drug containing, as a principal component, the crystal of the metal complex molecule. | 11-26-2015 |
20150351684 | OPTIMUM ADMINISTRATION FORM PROVIDING SYSTEM FOR MAGNETIC DRUG - [Object] A system capable of designing an optimum administration form of a magnetic drug is provided. | 12-10-2015 |
Patent application number | Description | Published |
20090116795 | OPTICAL WAVEGUIDE DEVICE - To provide a wiring technique which can easily realize the high speed communication between apparatuses and the conventional electrical communication at a low cost. The optic cable constituted of the core unit | 05-07-2009 |
20090269004 | OPTIC CABLE AND SENDING AND RECEIVING SUB-ASSEMBLY - To provide the sending and receiving sub-assembly in which the design has high degree of freedom and the optic cable has high light coupling factor. In the sending and receiving sub-assembly | 10-29-2009 |
20090297101 | Electric-Optic Conversion Module - Provided is an electrooptic conversion module, which can replace electronic parts more economically in case a malfunction occurs or in case an improvement is needed. In the electrooptic conversion module ( | 12-03-2009 |
20110142102 | CHANNEL ESTIMATION DEVICE AND METHOD, DEMODULATION DEVICE AND METHOD, AND FADING FREQUENCY DECISION DEVICE AND METHOD - In this invention, a channel estimation value of data symbols of a data channel is calculated by weighting and averaging pilot symbols in a parallel time multiplexing method. Also, a channel estimation value of data symbols during each data symbol interval is calculated by dividing data symbols in a slot into a plurality of data symbol intervals, selecting pilot symbols suitable for calculation of a channel estimation value of data symbols during each data symbol interval and weighting and averaging that pilot symbols. Also, a fading frequency is detected based on an inner product value of pilot symbols. Weighting factors are changed based on the detected fading frequency. Also, a channel estimation value is calculated by weighting and averaging pilot signals using a plurality of weighting sequences. The calculated channel estimation value is used to demodulate received data. The output data with the highest quality is selected by judging reliability of these plurality of demodulated data. It is also possible to select some weighting sequences based on the result of the reliability judgment of the demodulated data for predetermined period of time. In this case, after the selection, demodulation is performed by using these selected weighting sequences only. | 06-16-2011 |
20110201291 | MOBILE STATION AND MOBILE COMMUNICATION METHOD - A mobile station UE includes: a measuring unit ( | 08-18-2011 |
20110222632 | RECEIVING APPARATUS AND RECEIVING METHOD - A receiving apparatus configured to receive a downlink signal in which pilot symbols are mapped discontinuously on a frequency axis and on a time axis, includes: a first Fourier transform unit configured to perform Fourier transform on the downlink signal; an extraction unit configured to extract reference signals included in a predetermined band from the downlink signal that is Fourier transformed; an inverse Fourier transform unit configured to generate a first signal having a first window size by arranging the extracted reference signals on the frequency axis and by performing inverse Fourier transform on the reference signals arranged on the frequency axis; a time extraction unit configured to divide the first signal into a plurality of signals to extract a signal included in a second window; an adjustment unit configured to generate a second signal that includes the signal included in the second window and that has a window size similar to the first window size in which 0 is inserted in points other than the signal; a second Fourier transform unit configured to generate a third signal by performing Fourier transform on the second signal; and a received power calculation unit configured to calculate received power based on the third signal. | 09-15-2011 |
20110281612 | MOBILE STATION AND RADIO BASE STATION - A mobile station including a transmission power determining unit configured to determine a transmission power in an uplink shared channel, in accordance with a maximum transmission power value corresponding to power class of the mobile station, the number of resource blocks for the uplink shared channel, path loss between the mobile station and a radio base station which is a connection destination of the uplink shared channel, and transmission power control information received from the radio base station, where when receiving a maximum allowable transmission power value from the radio base station, the transmission power determining unit is configured to determine transmission power in the uplink shared channel, using the maximum allowable transmission power value instead of the maximum transmission power value corresponding to the power class of the mobile station. | 11-17-2011 |